Literature DB >> 6865785

Preparation and isolation of specific antibodies to complement components.

S Bhakdi, M Muhly, M Roth.   

Abstract

Mesh:

Substances:

Year:  1983        PMID: 6865785     DOI: 10.1016/s0076-6879(83)93054-9

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  9 in total

1.  Complement activation within the coeliac small intestine is localised to Brunner's glands.

Authors:  R B Gallagher; C P Kelly; S Neville; O Sheils; D G Weir; C F Feighery
Journal:  Gut       Date:  1989-11       Impact factor: 23.059

2.  In vitro fixation of C3d and C5b-9 on platelets by human platelet reactive antibodies.

Authors:  V Kiefel; A Salama; C Mueller-Eckhardt
Journal:  Blut       Date:  1989-01

3.  Mechanism of membrane damage by streptolysin-O.

Authors:  S Bhakdi; J Tranum-Jensen; A Sziegoleit
Journal:  Infect Immun       Date:  1985-01       Impact factor: 3.441

4.  Immunohistochemical detection of the terminal C5b-9 complement complex in children with glomerular diseases.

Authors:  H G Rus; F Niculescu; M Nanulescu; A Cristea; P Florescu
Journal:  Clin Exp Immunol       Date:  1986-07       Impact factor: 4.330

5.  Quantitative evaluation of the terminal C5b-9 complement complex by ELISA in human atherosclerotic arteries.

Authors:  F Niculescu; F Hugo; H G Rus; R Vlaicu; S Bhakdi
Journal:  Clin Exp Immunol       Date:  1987-08       Impact factor: 4.330

6.  Persistent complement activation on tumor cells in breast cancer.

Authors:  F Niculescu; H G Rus; M Retegan; R Vlaicu
Journal:  Am J Pathol       Date:  1992-05       Impact factor: 4.307

7.  Complement activation in human lymphoid germinal centres.

Authors:  J Zwirner; E Felber; P Schmidt; G Riethmüller; H E Feucht
Journal:  Immunology       Date:  1989-02       Impact factor: 7.397

8.  In vivo clearance studies of the terminal fluid-phase complement complex in rabbits.

Authors:  F Hugo; C Berstecher; S Krämer; W Fassbender; S Bhakdi
Journal:  Clin Exp Immunol       Date:  1989-07       Impact factor: 4.330

9.  Complement activation in amyloid plaques in Alzheimer's disease brains does not proceed further than C3.

Authors:  R Veerhuis; P van der Valk; I Janssen; S S Zhan; W E Van Nostrand; P Eikelenboom
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.